Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass. by Keymeulen, B, Walter, M, Mathieu, C, Kaufman, L, Gorus, F, Hilbrands, R, Vandemeulebroucke, E, Van de Velde, U, Crenier, L, De Block, C, Candon, S, Waldmann, H, Ziegler, A, Chatenoud, L, Pipeleers, D

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. by Keymeulen, B, Vandemeulebroucke, E, Ziegler, A, Mathieu, C, Kaufman, L, Hale, G, Gorus, F, Goldman, M, Walter, M, Candon, S, Schandene, L, Crenier, L, De Block, C, Seigneurin, J, De Pauw, P, Pierard, D, Weets, I, Rebello, P, Bird, P, Berrie, E, Frewin, M, Waldmann, H, Bach, J, Pipeleers, D, Chatenoud, L

E00-110 experiment at Jefferson Lab Hall A: Deeply virtual Compton scattering off the proton at 6 GeV by Defurne, M., Amaryan, M., Aniol, K. A., Beaumel, M., Benaoum, H., Bertin, P., Brossard, M., Camsonne, A., Chen, J.-P., Chudakov, E., Craver, B., Cusanno, F., de Jager, C. W., Deur, A., Feuerbach, R., Ferdi, C., Fieschi, J.-M., Frullani, S., Fuchey, E., Garçon, M., Garibaldi, F., Gavalian, G., Gilman, R., Gomez, J., Gueye, P., Guichon, P. A. M., Guillon, B., Hansen, O., Hayes, D., Higinbotham, D., Holmstrom, T., Hyde, C. E., Ibrahim, H., Igarashi, R., Jiang, X., Jo, H. S., Kaufman, L. J., Kelleher, A., Keppel, C. E., Kolarkar, A., Kuchina, E., Kumbartzki, G., Laveissière, G., LeRose, J. J., Lindgren, R., Liyanage, N., Lu, H.-J., Margaziotis, D. J., Mazouz, M., Meziani, Z.-E., McCormick, K., Michaels, R., Michel, B., Moffit, Bryan J., Munoz Camacho, C., Nanda, S., Nelyubin, V., Paremuzyan, R., Potokar, M., Ransome, R. D., Réal, J.-S., Reitz, B., Roblin, Y., Roche, J., Sabatié, F., Saha, A., Sirca, S., Slifer, K., Solvignon, P., Subedi, R., Sulkosky, V., Ulmer, P. E., Voutier, E., Wang, K., Weinstein, L. B., Wojtsekhowski, B., Zheng, X., Zhu, L., Gayou, Olivier, Monaghan, Peter, Qiang, Yi

Get full text